Renalytix plc
RNLXY· OTC
RNLXYRenalytix plc
Filed Feb 14, 2024 · 10-Q · 45 days after period end · 0000950170-24-015276
| Metric | Q2 2024 | Q2 2023 |
|---|---|---|
| Revenue | $709.00K | $1.19M |
| Net Income | -$8.49M | -$10.44M |
| EPS Diluted | -$0.09 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Renalytix plc · CIK 1811115 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 14, 2024 · 45 d after period end
